IntegriChain named by Gartner for 2019 Hype Cycle

  • 2019-08-25
Twice Gartner has recognized therapy data analysis firm IntegriChain. IntegriChain has a branch in Ambler and serves the community.

The company announced that the 2019 Gartner Hype Cycle for life Sciences Commercial Operations mentioned it as an example of a Commercial Analytics for Life Sciences and Revenue Management vendor. Examples are available on Gartner's website.

Kevin Leininger, Chief Executive Officer or IntegriChain, expressed the company's zeal to gain notoriety in commercial operations and market access for Life Sciences through Gartner. The company consolidated with daVIZta this year, which allows it to expand its analytic capabilities in order to help companies limit revenue loss, maintain complex contracts, and improve gross-to-net problems in the industry.

Combined with maximized trade and distribution solutions, investment in channels, and quality control, IntegriChain helps therapy patients start treatment sooner and maintain treatment longer. Over 165 clients are involved in the Life Sciences industry from corporations to small companies. The industry is also growing rapidly, so recognition by Gartner is a substantial accomplishment.

IntegriChain examines commercial data of the life sciences in order to help pharmaceutical companies develop therapy that patients are more likely to use and continue use over a longer period of time. Its main headquarters are in Philadelphia but it has branches in Ambler, New Jersey, Georgia, and India.

Research analysis companies likes IntegriChain often use poster printing to create visuals that best explain complicated data to clients.